Therapeutic options in Charcot–Marie–Tooth diseases

Charcot-Marie-Tooth Disease, Psychiatric Indicators and Quality of Life: A Systematic Review

(2014) Joana L.C. Cordeiro et al.   ASN Neuro

Postural stabilization and balance assessment in Charcot–Marie–Tooth 1A subjects

(2014) T. Lencioni et al.   GAIT & POSTURE

A Novel Role for Histone Deacetylase 6 in the Regulation of the Tolerogenic STAT3/IL-10 Pathway in APCs

(2014) Fengdong Cheng et al.   JOURNAL OF IMMUNOLOGY

Is overwork weakness relevant in Charcot–Marie–Tooth disease?

(2014) G Piscosquito et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A

(2014) Robert Fledrich et al.   NATURE MEDICINE

Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice

(2014) Jessica Nicks et al.   NEUROBIOLOGY OF DISEASE

Selected items from the Charcot-Marie-Tooth (CMT) Neuropathy Score and secondary clinical outcome measures serve as sensitive clinical markers of disease severity in CMT1A patients

(2014) Manoj Mannil et al.   NEUROMUSCULAR DISORDERS

The effects of resveratrol on chronic constriction injury of sciatic nerve in rats

(2014) H.A. Bagriyanik et al.   NEUROSCIENCE LETTERS

An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A

(2014) Shahram Attarian et al.   Orphanet Journal of Rare Diseases

Charcot-Marie-Tooth Disease Type 2A

(2014) Francesco Bombelli et al.   JAMA Neurology

Lower urinary tract functions in a series of Charcot-Marie-Tooth neuropathy patients

(2013) J. Krhut et al.   ACTA NEUROLOGICA SCANDINAVICA

Animal models and therapeutic prospects for Charcot-Marie-Tooth disease

(2013) Delphine Bouhy et al.   ANNALS OF NEUROLOGY

Ascorbic Acid and Sodium-Dependent Vitamin C Transporters in the Peripheral Nervous System: From Basic Science to Clinical Trials

(2013) Burkhard Gess et al.   ANTIOXIDANTS & REDOX SIGNALING

Motor Function Measure: Validation of a Short Form for Young Children With Neuromuscular Diseases

(2013) Capucine de Lattre et al.   ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION

Hip Dysplasia Is More Severe in Charcot-Marie-Tooth Disease Than in Developmental Dysplasia of the Hip

(2013) Eduardo N. Novais et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

The various Charcot–Marie–Tooth diseases

(2013) Jean-Michel Vallat et al.   CURRENT OPINION IN NEUROLOGY

Functional and dynamic response characteristics of a custom composite ankle foot orthosis for Charcot–Marie–Tooth patients

(2013) Janet S. Dufek et al.   GAIT & POSTURE

Sh3tc2 deficiency affects neuregulin-1/ErbB signaling

(2013) Estelle Arnaud Gouttenoire et al.   GLIA

Heterogeneity in the properties of NEFL mutants causing Charcot–Marie–Tooth disease results in differential effects on neurofilament assembly and susceptibility to intervention by the chaperone-inducer, celastrol

(2013) Benoit J. Gentil et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

The Diadenosine Homodinucleotide P18 Improves In Vitro Myelination in Experimental Charcot-Marie-Tooth Type 1A

(2013) Lucilla Nobbio et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice

(2013) Maurizio D’Antonio et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Sleep disorders in Charcot-Marie-Tooth disease type 1

(2013) M. Boentert et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Unknown

(2013) Mihai Moldovan et al.   MOLECULAR MEDICINE

AAV1.NT-3 Gene Therapy for Charcot–Marie–Tooth Neuropathy

(2013) Zarife Sahenk et al.   MOLECULAR THERAPY

Clinical implications of genetic advances in Charcot–Marie–Tooth disease

(2013) Alexander M. Rossor et al.   Nature Reviews Neurology

The protective effects of resveratrol on Schwann cells with toxicity induced by ethanol in vitro

(2013) Hongtu Yuan et al.   NEUROCHEMISTRY INTERNATIONAL

Joint Sparing Correction of Cavovarus Feet in Charcot-Marie-Tooth Disease

(2013) Tristan Barton et al.   Foot and Ankle Clinics

Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

(2012) Subash C. Gupta et al.   AAPS Journal

Validation of the Charcot-Marie-Tooth disease pediatric scale as an outcome measure of disability

(2012) Joshua Burns et al.   ANNALS OF NEUROLOGY

Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice

(2012) Ágnes Patzkó et al.   BRAIN

Murine therapeutic models for Charcot-Marie-Tooth (CMT) disease

(2012) R. Fledrich et al.   BRITISH MEDICAL BULLETIN

Coenzyme Q10 Therapy in Hereditary Motor Sensory Neuropathy Type VI with Novel Mitofusin 2 Mutation

(2012) Ryoichi Takahashi et al.   INTERNAL MEDICINE

Hypermyelination and overexpression of neuregulin-1 in thoracic sympathetic nerves in patients with primary palmar hyperhidrosis

(2012) Yuanrong Tu et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Anterior tibialis cmap amplitude correlations with impairment in CMT1A

(2012) Kelsey Komyathy et al.   MUSCLE & NERVE

Exploring the experience of fatigue in people with Charcot–Marie–Tooth disease

(2012) Gita M. Ramdharry et al.   NEUROMUSCULAR DISORDERS

Flexor digitorum superficialis opposition tendon transfer improves hand function in children with Charcot-Marie-Tooth disease: Case series

(2012) T. Estilow et al.   NEUROMUSCULAR DISORDERS

Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db- mouse, a type 2 diabetes model

(2012) T.-J. S. Shi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin

(2012) Zhao Zhong Chong et al.   PROGRESS IN NEUROBIOLOGY

Charcot-marie-tooth disease subtypes and genetic testing strategies

(2011) Anita S.D. Saporta et al.   ANNALS OF NEUROLOGY

Recent Advances in the Genetics of Hereditary Axonal Sensory-Motor Neuropathies Type 2

(2011) Senda Ajroud-Driss et al.   Current Neurology and Neuroscience Reports

Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease

(2011) Sinéad M. Murphy et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial

(2011) Davide Pareyson et al.   LANCET NEUROLOGY

HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1–induced Charcot-Marie-Tooth disease

(2011) Constantin d'Ydewalle et al.   NATURE MEDICINE

Hereditary peripheral neuropathies of childhood: An overview for clinicians

(2011) Jo M. Wilmshurst et al.   NEUROMUSCULAR DISORDERS

Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies

(2010) Jenny Epstein et al.   BRITISH JOURNAL OF NUTRITION

Genetic epidemiology of Charcot-Marie-Tooth in the general population

(2010) G. J. Braathen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Rapamycin Activates Autophagy and Improves Myelination in Explant Cultures from Neuropathic Mice

(2010) S. Rangaraju et al.   JOURNAL OF NEUROSCIENCE

Coexistence of two chronic neuropathies in a young child: Charcot-marie-tooth disease type 1A and chronic inflammatory demyelinating polyneuropathy

(2010) Wilson Marques et al.   MUSCLE & NERVE

Dlg1-PTEN Interaction Regulates Myelin Thickness to Prevent Damaging Peripheral Nerve Overmyelination

(2010) L. Cotter et al.   SCIENCE

Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

(2009) Camiel Verhamme et al.   BMC Medicine

The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study

(2009) C. Verhamme et al.   BRAIN

Ascorbic acid for Charcot–Marie–Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial

(2009) Joshua Burns et al.   LANCET NEUROLOGY

Effect of ascorbic acid in patients with Charcot–Marie–Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial

(2009) Joëlle Micallef et al.   LANCET NEUROLOGY

A network view of disease and compound screening

(2009) Eric E. Schadt et al.   NATURE REVIEWS DRUG DISCOVERY

Effect of Oral Curcumin on Déjérine-Sottas Disease

(2009) Joshua Burns et al.   PEDIATRIC NEUROLOGY

Dominant mutations in the tyrosyl-tRNA synthetase gene recapitulate inDrosophilafeatures of human Charcot–Marie–Tooth neuropathy

(2009) Erik Storkebaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Molecular mechanisms of inherited demyelinating neuropathies

(2008) Steven S. Scherer et al.   GLIA

Reliability of clinical outcome measures in Charcot-Marie-Tooth disease

(2007) A. Solari et al.   NEUROMUSCULAR DISORDERS